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distribution, biotransformation and elimination, that may 
influence the potency of a compound in cell culture. This is a 
chapter that could be read with profit by all those of us who have 
ever constructed a ‘dose/response curve’. Chapters s-10 deal in 
turn with specialised aspects and types of toxicity, in each case 
combining practical and theoretical aspects of their subject. 
The presentation of this book is of a high standard, sadly though 
it is only available in hard-back as yet. The style and structure of 
the different chapters is remarkably uniform for a multi-authored 
work. The illustrations, mostly taken from other books or from 
original papers, are generally aposite and helpful. Inevitably, there 
are a few minor editing errors. I noticed a few references in the 
text that fail to appear in the list at the back of the book. Figure 
2.6 has no actual picture (!), in my copy at least. In the chapter 
on ‘Ce!l Oncogenicity’ the oncogenes Erb-A and Erb-B are 
confused. 
To call this book a ‘wolf in sheep’s clothing’ does not perhaps 
convey quite the right impression, but it does seem to me that this 
is a book that is deserving of a wider readership than its specia,lised 
title is likely to attract. These days there is a wide range of 
experimental biologists using tissue culture methods, to investigate 
a multitude of problems besides toxicological ones. The basic 
principles, so clearly described in this book, are relevant to all 
these studies but are not allways appreciated as being so. 
C. Green 
This interesting book presents the Proceedings of a Satellite 
Symposium of the 2nd European Congress of Endocrinology held 
in Ljubljana, Slovenia, July 1990 and forms volume 19 of the 
Frontiers of Hormone Research series. The book contains 14 
chapters (although not numbered) from leading researchers in this 
field. The table oFcontents is adequate but the subject index would 
have been more useful if it had been more extensive. 
The use of antihormones in the field of molecular endocrinology 
has lead to some exciting advances in the understanding of health 
and in the treatment of disease. Recently, much attention (both 
in the scientific community and among the general public) has 
been focussed on two of the antihormones considered in this book, 
tamoxifcn and RU 486 (also referred to as R?J 38486). 
Tamoxifen is widely and electively used in the treatment of 
breast cancer. In addition, the prophylactic use of tamoxifen in 
women with a family Mstory of this disease is currently undergoing 
trials in a number of countries. These important aspects of 
tamoxifen therapy are given good coverage in this book in the 
chapter by Wolf and Jordan (pp, 87-98). The mechanism of the 
antioestrogcn action of tamoxifcn is discussed in the chapter by 
Ruh et al. (pp. 73-86), although the fascinating recent work on the 
ability of this drug to inhibit tumour cell growth independently of 
its antihormone action is not dealt with. The new pure 
antiocstrogen ICI 364384. which, unlike tamoxifen, is not a partial 
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oestrogen agonist, is considered in the chapter on oestrogen depri- 
vation in cancer by Nicholson and Walker (pp. 99-108). 
RU 486 has both antiprogestin and antiglucocorticoid activity 
and these arc discussed in the chapter by Philibcrt et al. (pp. 1-17). 
The latter action of this drug has enabled it to be used in the 
treatment of both Cushing’s syndrome and adrenal cancer. 
However, at present RU 486 is best known for its antiprogestin 
action in terminating early pregnancies when coadministered with 
a prostaglandin analogue. The chapter by Puri and Van Look (pp. 
127-167) on competitive progesterone antagonists for fertility 
control is a thorough account of the cellular and molecular 
mechanism of action of RU 486 (and similar compounds) and its 
many clinical applications. The influence of RU 486 on septic 
shock and on neurochcmical responses i  dealt with in the chapters 
by Lazar et al. (pp. 36-44) and by Etgen and Vathy (pp. 4%54), 
respectively, 
Overall this book is an informative collection of topics at the 
forefront of the treatment of hormone related conditions and will 
be of interest to a wide circle of researchers and clinicians. The 
high cost, however, probably means it will be purchased by 
libraries and institutions rather than by individuals. 
H. Wiseman 
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The transport of materials between nucleus and cytoplasm is an 
area of actiw investigation since it is involved in scvcrul cctlular 
functions. Through his book Paul Ayuttcr intends to introduce 
advanced students to the subject and approaches this aim by 
pfcsenling rclcvant flli1tCtGl in the fortn of six chapters. Stilrtitlg 
with un hWoduction to the fictd, the chapters deal in turn with 
methodology, structure and biological propertics of rctcvant 
nuctciir compancnts, the rote of transport proccsscs in the 
distribution of protcias and RN& bctwccn r~~cleus and 
cytoplasm, and finally the biological importance of nuctco- 
cytoplasmic transport, The longest ch:ipter deals with mcthodol- 
ogy since not only are in situ and in vitro approaches to transport 
studies compared, but critical appraisals arc also included of the 
methods far isolation of the nuclcer cnvctopc and its sub- 
fractionation. Etscwhcrc appropriate emphasis is given to the 
rcletivc roles of the ability of molccutcs to cntcr the nucleus and 
accumulatr hcrc, the function of protein/ RNA transport signals 
itnd the mcchanisni of translocetion through the pore, A model of 
